A controlled family study of cannabis users with and without psychosis
- PMID: 24309013
- PMCID: PMC4319545
- DOI: 10.1016/j.schres.2013.11.014
A controlled family study of cannabis users with and without psychosis
Abstract
Background: Cannabis is one of the most highly abused illicit drugs in the world. Several studies suggest a link between adolescent cannabis use and schizophrenia. An understanding of this link would have significant implications for legalization of cannabis and its medicinal value. The present study aims to determine whether familial morbid risk for schizophrenia is the crucial factor that underlies the association of adolescent cannabis use with the development of schizophrenia.
Methods: Consecutively obtained probands were recruited into four samples: sample 1: 87 non-psychotic controls with no drug use; sample 2: 84 non-psychotic controls with cannabis use; sample 3: 32 patients with a schizophrenia spectrum psychosis with no drug use; sample 4: 76 patients with schizophrenia spectrum psychosis with cannabis use. All cannabis using subjects used this drug during adolescence, and no other substance, with the exception of alcohol. Structured interviews of probands and family informants were used to obtain diagnostic information about probands and all their known relatives.
Results: There was an increased morbid risk for schizophrenia in relatives of the cannabis using and non-using patient samples compared with their respective non-psychotic control samples (p=.002, p<.001 respectively). There was no significant difference in morbid risk for schizophrenia between relatives of the patients who use or do not use cannabis (p=.43).
Conclusions: The results of the current study suggest that having an increased familial morbid risk for schizophrenia may be the underlying basis for schizophrenia in cannabis users and not cannabis use by itself.
Published by Elsevier B.V.
Conflict of interest statement
All co-authors submit that they have no conflicts of interest to report.
Comment in
-
Re: Caution urged in interpreting a negative study of cannabis use and schizophrenia: a response to Dr. Christine Miller.Schizophr Res. 2014 Apr;154(1-3):121. doi: 10.1016/j.schres.2014.02.012. Epub 2014 Mar 11. Schizophr Res. 2014. PMID: 24630137 Free PMC article. No abstract available.
-
Caution urged in interpreting a negative study of cannabis use and schizophrenia.Schizophr Res. 2014 Apr;154(1-3):119-20. doi: 10.1016/j.schres.2014.02.014. Epub 2014 Mar 11. Schizophr Res. 2014. PMID: 24636304 No abstract available.
References
-
- Andréasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand. 1989;79(5):505–510. - PubMed
-
- Boydell J, Dean K, Dutta R, Giouroukou E, Fearon P, Murray R. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Schizophr Res. 2007;93(1–3):203–210. - PubMed
-
- Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117–1127. - PubMed
-
- Deiana S. Medical use of cannabis. Cannabidiol: A new light for schizophrenia? Drug Test Anal. 2013;5(1):46–51. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
